The role of adjuvants in vaccines for seasonal and pandemic influenza
- 1 November 2010
- Vol. 28 (50) , 8043-8045
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Evaluation of Vaccines for H5N1 Influenza Virus in Ferrets Reveals the Potential for Protective Single-Shot ImmunizationJournal of Virology, 2009
- Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvantImmunology & Cell Biology, 2009
- Towards an understanding of the adjuvant action of aluminiumNature Reviews Immunology, 2009
- Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccinesInternational Immunology, 2006
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) VaccineNew England Journal of Medicine, 2006
- ISCOMTM‐based vaccines: The second decadeImmunology & Cell Biology, 2005
- A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responsesProceedings of the National Academy of Sciences, 2004
- Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine TargetThe Journal of Immunology, 2003
- Compromised Influenza Virus-Specific CD8+-T-Cell Memory in CD4+-T-Cell-Deficient MiceJournal of Virology, 2002
- Isolation, Structure Elucidation, and Synthesis of a Macrophage Stimulatory Lipopeptide from Mycoplasma fermentans Acting at Picomolar ConcentrationJournal of Experimental Medicine, 1997